View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Announcing DPharm 2018 Dates and Keynotes


  • July 1, 2018

  • The Conference Forum has announced that the 8th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference will take place on September 25-26, 2018 at the Boston Marriott Copley Place in Boston, MA, with a full day dedicated to Mobile in Clinical Trials on September 24.

    “DPharm 2018 is the year of all things digital, patient data ownership and new approaches to optimize clinical operation systems,” said Valerie Bowling, Executive Director, the Conference Forum.

    2018 keynotes include Indrek Onnik of the E-Estonia Showroom, a partner of the Estonian Government. Indrek will tell the DPharm audience why and how Estonia became the first and fastest digital republic where patients own their own data, and about their modern view of clinical trials.

    Amazon Web Services’ Mark Johnston, who heads up the Health Care and Life Sciences division, will provide a keynote on how Amazon develops a culture of innovation. Also keynoting is one of the most prominent leaders in the Regenerative Medicine space, Dr Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine. Anthony will give an unbelievable insight in how regenerative medicine, for example 3D printing of organs, will impact clinical trials.

    The DPharm patient keynote for 2018 is America’s Got Talent Teen Cancer Survivor and Patient Advocate, Caly Bevier.

    Back by popular demand, keynote speaker Dr Chip Bell, the country’s preeminent author and speaker on customer service, will entertain the DPharm audience with his unusual style of teaching the “how” in creating a culture of service in drug development.

    Legendary investor Esther Dyson, Executive Founder, Way to Wellville and Board Member, 23andMe, is confirmed to judge DPharm Idol. This annual live show features a select group of innovators, who present what they believe is a disruptive service or technology that could be a changing force for clinical trials.

    VIP Clinical Operation Heads new to DPharm include John Varaklis, Head of Global Clinical Operations, Roche (pRED) and Rob Goodwin, VP, Operations Center of Excellence, Global Product Development, Pfizer.

    For the first time, Dr Sylke Poehling, SVP and Global Head, Strategy, Portfolio & Clinical Operations, Pharma Research & Early Development, Roche joins veteran co-chairs Dr Andreas Koester, VP, Innovation, R&D Operations, Janssen and Craig Lipset, Head of Clinical Innovation, Pfizer to shake up the thinking on traditional routines in clinical operations to reduce the burden on patients, investigators and sites.

    DPharm 2018 is divided into the following sections: keynotes, strategic level talks, pharma innovation reporting, new and advanced technologies, patient data access and ownership, digital biomarkers, digital/virtual trials, AI/machine learning, clinical research as a care option (CRAACO), and service as a disruptor in R&D.

    Reserve your spot now. Never stop innovating!